Rosetta Genomics (ROSG)

Add to Watchlists
Create an Alert
3.62 -0.20  -5.24% NASDAQ Sep 19, 8:00PM BATS Real time Currency in USD
View Full Chart
ROSG Price Chart
View All Events

ROSG Events

Date Type Description
04/01/2014 10:00 EDT Misc Rosetta Genomics, Ltd. Q4 2013 Earning Conference Call
03/31/2014 Earnings Rosetta Genomics, Ltd. Q4 2013 Earning Result
View All Performance Charts

ROSG Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Rosetta Genomics is up 9.73% over the last year vs S&P 500 Total Return up 18.96%, BG Medicine down 38.22%, and LipoScience down 37.72%.

Get Quote for

Portfolio Strategies Featuring ROSG

Did Rosetta Genomics make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

ROSG Profile

Rosetta Genomics Ltd is engaged in the development and commercialization of new diagnostic tests and therapeutics based on a group of genes known as microRNAs.

ROSG Excel Add-In Codes

  • Name: =YCI("ROSG","name")
  • Description: =YCI("ROSG","description")
  • Sector: =YCI("ROSG","sector")
  • Industry: =YCI("ROSG","industry")
  • Est. Current Fiscal Year End: =YCI("ROSG","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.


You've hit the 10 page limit on YCharts.

Experience the power of YCharts Professional.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.


Start your free 14 Day Trial.

{{}} No credit card required.

Already a subscriber? Sign in.